Medscape walks through the basics of orforglipron, Lilly's oral GLP-1 sold as Foundayo, as the pill moves toward approval in Europe.
Recap by typeshit. Full story at Medscape.
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
11:37
A 63 year old creator walks through six months on tirzepatide and a 48 pound drop, sharing a personal account of the experience.
Philstar Life looks at famous names linked to Ozempic for weight loss. Only a search title came through, so details are thin until you open the source.
An international food and agribusiness expert links growing interest in fibre to the spread of GLP-1 drugs. Details are thin beyond the claim itself.
ETFDb lists the REX Peptide ETF among this week's new funds. It targets companies working on peptide drugs, supplements, cosmetics and devices.
A survey presented at the EADV 2026 Congress found more nail lifting and color changes in GLP-1 users, but the link weakened after adjustments.
Loading…